Tff Pharmaceuticals Inc’s Market Journey: Closing Weak at 1.60, Down -4.76

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Tff Pharmaceuticals Inc (NASDAQ: TFFP) was $1.60 for the day, down -4.76% from the previous closing price of $1.68. In other words, the price has decreased by -$4.76 from its previous closing price. On the day, 0.3 million shares were traded. TFFP stock price reached its highest trading level at $1.6732 during the session, while it also had its lowest trading level at $1.54.

Ratios:

Our analysis of TFFP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.63. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

On February 08, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $31.

On December 07, 2020, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $36.B. Riley Securities initiated its Buy rating on December 07, 2020, with a $36 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TFFP now has a Market Capitalization of 5545664 and an Enterprise Value of 1232591. Its current Enterprise Value per Revenue stands at 1.025 whereas that against EBITDA is -0.065.

Stock Price History:

Over the past 52 weeks, TFFP has reached a high of $11.00, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is -21.84%, while the 200-Day Moving Average is calculated to be -49.95%.

Shares Statistics:

TFFP traded an average of 72.91K shares per day over the past three months and 135720 shares per day over the past ten days. A total of 3.47M shares are outstanding, with a floating share count of 3.10M. Insiders hold about 10.44% of the company’s shares, while institutions hold 19.06% stake in the company. Shares short for TFFP as of 1730332800 were 171957 with a Short Ratio of 2.36, compared to 1727654400 on 131287. Therefore, it implies a Short% of Shares Outstanding of 171957 and a Short% of Float of 5.0200000000000005.

Earnings Estimates

The current market rating for Tff Pharmaceuticals Inc (TFFP) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.73, with high estimates of -$0.73 and low estimates of -$0.73.

Analysts are recommending an EPS of between -$4.28 and -$4.28 for the fiscal current year, implying an average EPS of -$4.28. EPS for the following year is -$3.77, with 1.0 analysts recommending between -$3.77 and -$3.77.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $150k to a low estimate of $150k. As of the current estimate, Tff Pharmaceuticals Inc’s year-ago sales were $234.76kFor the next quarter, 1 analysts are estimating revenue of $150k. There is a high estimate of $150k for the next quarter, whereas the lowest estimate is $150k.

A total of 1 analysts have provided revenue estimates for TFFP’s current fiscal year. The highest revenue estimate was $1.15M, while the lowest revenue estimate was $1.15M, resulting in an average revenue estimate of $1.15M. In the same quarter a year ago, actual revenue was $733.87kBased on 1 analysts’ estimates, the company’s revenue will be $800k in the next fiscal year. The high estimate is $800k and the low estimate is $800k.

Most Popular